Kiebert, Gwendoline M <br/><br/>
Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazine.  [electronic resource] 

 -  Cancer investigation  2003 
 - 821-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-7907 
<br/><br/><label>Standard No.: </label>10.1081/cnv-120025084  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Cognition<br/>Dacarbazine--adverse effects<br/>Emotions<br/>Female<br/>Health Status<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Quality of Life<br/>Skin Neoplasms--drug therapy<br/>Sleep<br/>Survival Analysis<br/>Temozolomide